Comparative Pharmacology
Head-to-head clinical analysis: ETHINYL ESTRADIOL AND NORELGESTROMIN versus PREMPRO PREMARIN CYCRIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ETHINYL ESTRADIOL AND NORELGESTROMIN versus PREMPRO PREMARIN CYCRIN.
ETHINYL ESTRADIOL AND NORELGESTROMIN vs PREMPRO (PREMARIN;CYCRIN)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination contraceptive: estrogen (ethinyl estradiol) suppresses gonadotropin release via negative feedback on pituitary; progestin (norelgestromin) thickens cervical mucus and inhibits ovulation.
PREMPRO combines conjugated estrogens (PREMARIN) and medroxyprogesterone acetate (CYCRIN). Estrogens bind to estrogen receptors (ERα and ERβ), activating gene transcription involved in cell growth, differentiation, and function. Progestins like medroxyprogesterone acetate bind to progesterone receptors, antagonizing estrogen-induced endometrial proliferation and reducing risk of endometrial hyperplasia.
One transdermal patch (releasing 0.035 mg ethinyl estradiol and 0.150 mg norelgestromin per 24 hours) applied once weekly for 3 weeks, followed by 1 week patch-free.
One tablet (0.625 mg conjugated estrogens/2.5 mg medroxyprogesterone acetate or 0.625 mg/5 mg) orally once daily.
None Documented
None Documented
Ethinyl estradiol has a terminal elimination half-life of approximately 13-27 hours (mean ~17 hours). Norelgestromin has a terminal half-life of about 28 hours. These half-lives support once-weekly dosing of the transdermal system, achieving steady-state by the second application.
Conjugated estrogens: 10-24 hours (terminal); medroxyprogesterone acetate: 12-17 hours. Clinical context: steady-state reached after 5-7 days.
Ethinyl estradiol and norelgestromin are excreted primarily via urine and feces. Ethinyl estradiol undergoes extensive metabolism; about 40% is excreted in urine and 60% in feces as glucuronide and sulfate conjugates. Norelgestromin is metabolized to norgestrel and other metabolites; approximately 45% is excreted in urine and 35% in feces.
Conjugated estrogens and medroxyprogesterone acetate are primarily excreted in urine as glucuronide and sulfate conjugates; about 10% excreted in feces via bile.
Category D/X
Category C
Estrogen
Estrogen/Progestin Combination